Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Slaby, Ondrej ^a,b   Jancovicova, Jana ^c   Lakomy, Radek ^a   Svoboda, Marek ^a   Poprach, Alexandr ^a   Fabian, Pavel ^a   Kren, Leos ^d   Michalek, Jaroslav ^b   Vyzula, Rostislav ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^b University Cell Immunotherapy Center   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

^d UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MESSENGER RNA; MIRN106 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MALE; METASTASIS; MICROARRAY ANALYSIS; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; CASE CONTROL STUDY; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; KIDNEY; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR RECURRENCE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77954265970     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-90     Document Type: Article

References (31)

1. Renal Cell Carcinoma. JP Richie E Jonasch PW Kantoff, Holland-Frei Cancer Medicine Hamilton (Canada), BC Decker, Edited by: Kufe WD, Bast RC, Hait WN, et al, 7 2006 1401 1410
2. Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. RM Bukowski, Cancer 2009 115 2273 2281 10.1002/cncr.24226 19402065
3. Recent developments in the pathology of renal tumors: morphology and molecular characteristics of select entities. BC Yan AC Mackinnon HA Al-Ahmadie, Arch Pathol Lab Med 2009 133 102610 32
4. MicroRNA control of signal transduction. M Inui G Martello S Piccolo, Nat Rev Mol Cell Biol 2010 11 4 252 263 20216554
5. Non-coding RNAs: a key to future personalized molecular therapy? M Galasso M Elena Sana S Volinia, Genome Med 2010 18 2(2) 12 10.1186/gm133
6. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. BD Brown L Naldini, Nat Rev Genet 2009 10 578 585 10.1038/nrg2628 19609263
7. MicroRNAs: novel biomarkers for human cancer. CL Bartels GJ Tsongalis, Clin Chem 2009 55 623 631 10.1373/clinchem.2008.112805 19246618
8. Oncomirs - microRNAs with a role in cancer. A Esquela-Kerscher FJ Slack, Nat Rev Cancer 2006 6 259 269 10.1038/nrc1840 16557279
9. MicroRNAs in Cancer. R Garzon GA Calin CM Croce, Annu Rev Med 2009 60 167 179 10.1146/annurev.med.59.053006.104707 19630570
10. MicroRNA expression and function in cancer. R Garzon M Fabbri A Cimmino GA Calin CM Croce, Trends Mol Med 2006 12 580 587 10.1016/j.molmed.2006.10.006 17071139
11. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. O Slaby M Svoboda J Michalek R Vyzula, Mol Cancer 2009 8 102 10.1186/1476-4598-8-102 19912656
12. DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma. O Slaby M Svoboda J Michalek R Vyzula, Klin Onkol 2009 22 5 202 209 19886357
13. MicroRNA profiling of human kidney cancer subtypes. D Petillo EJ Kort J Anema KA Furge XJ Yang BT Teh, Int J Oncol 2009 35 1 109 114 10.3892/ijo-00000318 19513557
14. Identification of a microRNA panel for clear-cell kidney cancer. D Juan G Alexe T Antes H Liu A Madabhushi C Delisi S Ganesan G Bhanot LS Liou, Urology 2010 75 4 835 841 10.1016/j.urology.2009.10.033 20035975
15. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. C Nakada K Matsuura Y Tsukamoto M Tanigawa T Yoshimoto T Narimatsu LT Nguyen N Hijiya T Uchida F Sato H Mimata M Seto M Moriyama, J Pathol 2008 216 4 418 427 10.1002/path.2437 18925646
16. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. M Jung HJ Mollenkopf C Grimm I Wagner M Albrecht T Waller C Pilarsky M Johannsen C Stephan H Lehrach W Nietfeld T Rudel K Jung G Kristiansen, J Cell Mol Med 2009 13 9B 3918 3928 10.1111/j.1582-4934. 2009.00705.x 19228262
17. Micro-RNA profiling in kidney and bladder cancers. F Gottardo CG Liu M Ferracin GA Calin M Fassan P Bassi C Sevignani D Byrne M Negrini F Pagano LG Gomella CM Croce R Baffa, Urol Oncol 2007 25 5 387 392 17826655
18. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. Z Yi Y Fu S Zhao X Zhang C Ma, J Cancer Res Clin Oncol 2010 136 6 855 862 10.1007/s00432-009-0726-x 19921256
19. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. TF Chow YM Youssef E Lianidou AD Romaschin RJ Honey R Stewart KT Pace GM Yousef, Clin Biochem 2010 43 1-2 150 158 10.1016/j.clinbiochem.2009.07.020 19646430
20. Microarray analysis of microRNA expression in renal clear cell carcinoma. Y Huang Y Dai J Yang T Chen Y Yin M Tang C Hu L Zhang, Eur J Surg Oncol 2009 35 10 1119 1123 19443172
21. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. TF Chow M Mankaruos A Scorilas Y Youssef A Girgis S Mossad S Metias Y Rofael RJ Honey R Stewart KT Pace GM Yousef, J Urol 2010 183 2 743 751 10.1016/j.juro.2009.09.086 20022054
22. miR-155 gene: a typical multifunctional microRNA. I Faraoni FR Antonetti J Cardone E Bonmassar, Biochim Biophys Acta 2009 1792 6 497 505 19268705
23. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. DL Gibbons W Lin CJ Creighton ZH Rizvi PA Gregory GJ Goodall N Thilaganathan L Du Y Zhang A Pertsemlidis JM Kurie, Genes Dev 2009 23 18 2140 2151 10.1101/gad.1820209 19759262
24. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. U Burk J Schubert U Wellner O Schmalhofer E Vincan S Spaderna T Brabletz, EMBO Rep 2008 9 582 589 10.1038/embor.2008.74 18483486
25. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. YX Wang XY Zhang BF Zhang CQ Yang XM Chen HJ Gao, J Dig Dis 2010 11 1 50 54 10.1111/j.1751-2980.2009.00413.x 20132431
26. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Guo Y Miao B Xiao R Huan Z Jiang D Meng Y Wang, J Gastroenterol Hepatol 2009 24 4 652 657 10.1111/j.1440-1746.2008.05666.x 19175831
27. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Y Li W Tan TW Neo MO Aung S Wasser SG Lim TM Tan, Cancer Sci 2009 100 7 1234 1242 10.1111/j.1349-7006.2009.01164.x 19486339
28. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. AB Hui M Lenarduzzi T Krushel L Waldron M Pintilie W Shi B Perez-Ordonez I Jurisica B O'Sullivan J Waldron P Gullane B Cummings FF Liu, Clin Cancer Res 2010 16 4 1129 1139 10.1158/1078-0432.CCR-09-2166 20145181
29. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. F Petrocca A Vecchione CM Croce, Cancer Res 2008 68 20 8191 8194 10.1158/0008-5472.CAN-08-1768 18922889
30. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. B Bierie HL Moses, Nat Rev Cancer 2006 6 7 506 520 10.1038/nrc1926 16794634
31. TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect. A Joshi D Cao, Front Biosci 2010 15 180 194 10.2741/3614 20036814